NCEL
NewcelX Ltd.
NASDAQ · Healthcare · Biotechnology · CH
$3.35
+0.00%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$0.65
- Revenue estimate
- —
Latest reported
- Last report date
- May 15, 2024
- EPS actual
- -$0.00
- EPS estimate
- -$8.40
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +97.2%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027